Semaglutids is a glucagon-like peptide-1 (GLP-1) agonist
For weight loss specifically, tesamorelin is not FDA-approved, and it does not drive the kind of scale-level reduction that GLP-1s produce
Tirzepatide works on the GIP and GLP-1 pathways to help regulate sugar, but also decreasing appetite and gastric emptying time
If you are in a study involving medications, however, you are going to be much more likely to stay on the medication than a real-world patient
And the evidence connecting them to GLP-1 medications has grown substantially over the past two years
2 Although known for numerous advantages, MTX use can be detrimental to several viscera, causing serious toxic consequences on respiratory tract, hepatic tissue, and bone marrow